"Better manipulation of a catheter in the vasculature could result in better outcomes."
— Peter Altman, PhD, president/CEO of BioCardia, discussing the benefits of the company's new product, "BioCardia's Morph AccessPro is tool for PAD procedures."
Subscribe to BioWorld™ news services
"Better manipulation of a catheter in the vasculature could result in better outcomes."
— Peter Altman, PhD, president/CEO of BioCardia, discussing the benefits of the company's new product, "BioCardia's Morph AccessPro is tool for PAD procedures."